RecruitingEarly Phase 1NCT06482853

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension


Sponsor

Milton S. Hershey Medical Center

Enrollment

52 participants

Start Date

Jan 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Obesity is a global health concern that is associated with high blood pressure and an increased risk for developing cardiovascular disease. The purpose of this study is to find out if the investigational drug angiotensin-(1-7) can improve cardiovascular health in people with obesity and high blood pressure.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a naturally occurring molecule called angiotensin-(1-7) can lower blood pressure and improve heart and blood vessel function in people who are obese and have high blood pressure. This molecule is part of the body's own blood pressure regulation system and may offer a new treatment approach. **You may be eligible if...** - You are 18–65 years old, of any race or sex - Your BMI is between 30 and 45 (obese range) - You have pre-hypertension or hypertension (blood pressure above 120/80 mmHg), with or without blood pressure medication (up to 2 medications) - You can speak and read English **You may NOT be eligible if...** - You are taking more than 2 blood pressure medications - You have a secondary cause of hypertension (such as a hormone-producing tumor or adrenal disease) - You are pregnant or nursing - You have significant heart, kidney, or liver disease - You have a history of alcohol or substance abuse Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAngiotensin-(1-7)

This is a biologically active endogenous angiotensin peptide that may play an important role in regulation of blood pressure.

DRUGSaline

Saline will be used as the placebo comparator.


Locations(1)

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06482853


Related Trials